BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24105833)

  • 21. Plant NADPH-cytochrome P450 oxidoreductases.
    Jensen K; Møller BL
    Phytochemistry; 2010 Feb; 71(2-3):132-41. PubMed ID: 19931102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome analyses of Streptomyces peucetius ATCC 27952 for the identification and comparison of cytochrome P450 complement with other Streptomyces.
    Parajuli N; Basnet DB; Chan Lee H; Sohng JK; Liou K
    Arch Biochem Biophys; 2004 May; 425(2):233-41. PubMed ID: 15111132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxynitrite inactivation of human cytochrome P450s 2B6 and 2E1: heme modification and site-specific nitrotyrosine formation.
    Lin HL; Myshkin E; Waskell L; Hollenberg PF
    Chem Res Toxicol; 2007 Nov; 20(11):1612-22. PubMed ID: 17907788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probing the structure of the linker connecting the reductase and heme domains of cytochrome P450BM-3 using site-directed mutagenesis.
    Govindaraj S; Poulos TL
    Protein Sci; 1996 Jul; 5(7):1389-93. PubMed ID: 8819171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrostatic properties deduced from refined structures of NADH-cytochrome b5 reductase and the other flavin-dependent reductases: pyridine nucleotide-binding and interaction with an electron-transfer partner.
    Nishida H; Miki K
    Proteins; 1996 Sep; 26(1):32-41. PubMed ID: 8880927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxygen activation and electron transfer in flavocytochrome P450 BM3.
    Ost TW; Clark J; Mowat CG; Miles CS; Walkinshaw MD; Reid GA; Chapman SK; Daff S
    J Am Chem Soc; 2003 Dec; 125(49):15010-20. PubMed ID: 14653735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
    Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
    J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional interactions in cytochrome P450BM3. Fatty acid substrate binding alters electron-transfer properties of the flavoprotein domain.
    Murataliev MB; Feyereisen R
    Biochemistry; 1996 Nov; 35(47):15029-37. PubMed ID: 8942669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [NADPH-cytochrome P450 reductase, not only the partner of cytochrome P450].
    Wiśniewska A; Jagiełło K; Mazerska Z
    Postepy Biochem; 2009; 55(3):272-8. PubMed ID: 19928583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cytochrome P450 gene family CYP157 does not contain EXXR in the K-helix reducing the absolute conserved P450 residues to a single cysteine.
    Rupasinghe S; Schuler MA; Kagawa N; Yuan H; Lei L; Zhao B; Kelly SL; Waterman MR; Lamb DC
    FEBS Lett; 2006 Nov; 580(27):6338-42. PubMed ID: 17092500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies for the development of highly selective cytochrome P450 inhibitors: Several CYP targets in current research.
    Zhao L; Sun N; Tian L; Zhao S; Sun B; Sun Y; Zhao D
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2016-2024. PubMed ID: 31257085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Residue 285 in cytochrome P450 2B4 lacking the NH(2)-terminal hydrophobic sequence has a role in the functional association of NADPH-cytochrome P450 reductase.
    Schulze J; Tschöp K; Lehnerer M; Hlavica P
    Biochem Biophys Res Commun; 2000 Apr; 270(3):777-81. PubMed ID: 10772901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of the FMN-Domain of Human Cytochrome P450 Oxidoreductase in Its Promiscuous Interactions With Structurally Diverse Redox Partners.
    Esteves F; Campelo D; Gomes BC; Urban P; Bozonnet S; Lautier T; Rueff J; Truan G; Kranendonk M
    Front Pharmacol; 2020; 11():299. PubMed ID: 32256365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of unusual amino acid residues in the proximal and distal heme regions of a plant P450, CYP73A1.
    Schalk M; Nedelkina S; Schoch G; Batard Y; Werck-Reichhart D
    Biochemistry; 1999 May; 38(19):6093-103. PubMed ID: 10320335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of selectivity determinants in CYP monooxygenases by modelling and systematic analysis of sequence and structure.
    Seifert A; Pleiss J
    Curr Drug Metab; 2012 Feb; 13(2):197-202. PubMed ID: 22208534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterologous expression of an endogenous rat cytochrome b(5)/cytochrome b(5) reductase fusion protein: identification of histidines 62 and 85 as the heme axial ligands.
    Davis CA; Dhawan IK; Johnson MK; Barber MJ
    Arch Biochem Biophys; 2002 Apr; 400(1):63-75. PubMed ID: 11913972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytochrome P450 (CYP) enzymes and the development of CYP biosensors.
    Schneider E; Clark DS
    Biosens Bioelectron; 2013 Jan; 39(1):1-13. PubMed ID: 22809523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An electron transfer competent structural ensemble of membrane-bound cytochrome P450 1A1 and cytochrome P450 oxidoreductase.
    Mukherjee G; Nandekar PP; Wade RC
    Commun Biol; 2021 Jan; 4(1):55. PubMed ID: 33420418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystal structure of a ferredoxin reductase for the CYP199A2 system from Rhodopseudomonas palustris.
    Xu F; Bell SG; Peng Y; Johnson EO; Bartlam M; Rao Z; Wong LL
    Proteins; 2009 Dec; 77(4):867-80. PubMed ID: 19626710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple NADPH-cytochrome P450 reductases from Trypanosoma cruzi suggested role on drug resistance.
    Portal P; Fernández Villamil S; Alonso GD; De Vas MG; Flawiá MM; Torres HN; Paveto C
    Mol Biochem Parasitol; 2008 Jul; 160(1):42-51. PubMed ID: 18455247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.